Metraipolis › archive › dc_d3fd23dfc60c

A broad-spectrum SARS-CoV-2 RBD vaccine with selected high-impact mutations and novel adjuvant induces durable T cell response and broad protection in mice — Europe PMC PMID:41693861

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41693861
DOI
10.3389/fcimb.2025.1690554
License (as archived)
solo-consultazione
Archived
2026-11-06T10:10:19.236Z
SHA-256 of the archived text
56cebac34b4ae94f17ae321cf3274b6ed05bac9a967e2d9233e107302425608b
Stable URL of this page
https://metraipolis.com/documento/dc_d3fd23dfc60c

How to cite

A broad-spectrum SARS-CoV-2 RBD vaccine with selected high-impact mutations and novel adjuvant induces durable T cell response and broad protection in mice — Europe PMC PMID:41693861 — Europe PMC (en), https://europepmc.org/article/MED/41693861 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d3fd23dfc60c (Metraipolis archive dc_d3fd23dfc60c, sha256 56cebac34b4ae94f17ae321cf3274b6ed05bac9a967e2d9233e107302425608b)
BibTeX
@misc{dcd3fd23dfc60c,
  title = {A broad-spectrum SARS-CoV-2 RBD vaccine with selected high-impact mutations and novel adjuvant induces durable T cell response and broad protection in mice — Europe PMC PMID:41693861},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41693861},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d3fd23dfc60c; sha256 56cebac34b4ae94f17ae321cf3274b6ed05bac9a967e2d9233e107302425608b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41693861. Agents can read the archived copy with the MCP tool read_document.